| CYCN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CYCN market cap history going back to 3/18/2019:
Also see: CYCN Shares Outstanding History and CYCN YTD Return |
CYCN Market Cap History — Cyclerion Therapeutics Capitalization Over Time
As of 7/31/2026 Cyclerion Therapeutics has a market cap of 16.10 million. Investors often follow the CYCN market cap history to compare the size of the company over time.
This page shows CYCN market capitalization trends over time, with 31 market cap datapoints presented, dating back to 3/18/2019.
| CYCN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CYCN Historical Market Cap: -33.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CYCN Stock Price Chart |
| About Cyclerion Therapeutics Inc |
| Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for serious diseases. Co.'s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. Olinciguat is a vascular sGC stimulator that the Co. intends to out-license for cardiovascular diseases. Co. operates through the human therapeutics segment. We show 31 historical shares outstanding datapoints in our CYCN shares outstanding history coverage, used to compute CYCN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CYCN market cap history over the course of time is important for investors interested in comparing CYCN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CYCN versus a peer is one thing; comparing CYCN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CYCN can fluctuate over the course of history. With this page we aim to empower investors researching CYCN by allowing them to research the CYCN market cap history. |
| CYCN Current Stock Quote |
Quotes delayed 20 minutes  Free CYCN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CYCN Share Performance |
| Market Cap Peers |
| Cyclerion Therapeutics (CYCN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CYH Market Cap History CYPH Market Cap History CYRX Market Cap History CYT Market Cap History CYTH Market Cap History CYTK Market Cap History CYTR Market Cap History CYTX Market Cap History DARE Market Cap History DAWN Market Cap History More Healthcare companies » |
CYCN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
